Eesti - eesti - Ravimiamet

richard bittner ag - nikotiin - pressitud loseng - 1,5mg 60tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastilised ained - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - bensüdamiin+tsetüülpüridiinkloriid - loseng - 3mg+1mg 32tk; 3mg+1mg 24tk; 3mg+1mg 40tk; 3mg+1mg 16tk

Eesti - eesti - Ravimiamet

reckitt benckiser (poland) s.a. - flurbiprofeen - loseng - 8,75mg 12tk; 8,75mg 36tk; 8,75mg 8tk; 8,75mg 24tk; 8,75mg 16tk

Eesti - eesti - Ravimiamet

engelhard arzneimittel gmbh & co. kg - lidokaiin - loseng - 8mg 60tk; 8mg 36tk; 8mg 24tk; 8mg 2tk; 8mg 10tk; 8mg 50tk; 8mg 100tk

Eesti - eesti - Ravimiamet

pierre fabre medicament - nikotiin - loseng - 1,5mg 36tk; 1,5mg 48tk; 1,5mg 12tk; 1,5mg 24tk; 1,5mg 84tk; 1,5mg 72tk; 1,5mg 204tk; 1,5mg 96tk

Eesti - eesti - Ravimiamet

reckitt benckiser (poland) s.a. - flurbiprofeen - loseng - 8,75mg 16tk; 8,75mg 24tk

Eesti - eesti - Ravimiamet

pierre fabre medicament - nikotiin - loseng - 1,5mg 204tk; 1,5mg 84tk; 1,5mg 12tk; 1,5mg 96tk; 1,5mg 60tk; 1,5mg 36tk; 1,5mg 72tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - bensüdamiin+tsetüülpüridiinkloriid - loseng - 3mg+1mg 8tk; 3mg+1mg 40tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - bensüdamiin+tsetüülpüridiinkloriid - loseng - 3mg+1mg 40tk; 3mg+1mg 24tk